Topic: Advanced NSCLC Frequency of Uncommon EGFR Mutations in CR

被引：0
|
作者：
Porras Gutierrez, R. [1 ]
Corrales-Rodriguez, L. [2 ]
Abbas, J. [1 ]
Mendez, A. [1 ]
机构：
[1] CCSS, San Jose, Costa Rica
[2] CIMCA CCSS, San Jose, Costa Rica
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 11期
关键词：
EGFR; uncommon mutations; adenocarcinoma;
D O I：
10.1016/j.jtho.2019.09.176
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.13
引用
收藏
页码：S1189 / S1189
页数：1
相关论文
共 50 条
  • [1] Frequency and Detectability of Uncommon EGFR Mutations in NSCLC
    O'Sullivan, H. M.
    MacMahon, S.
    Cui, W.
    Milner-Watts, C.
    Tokaca, N.
    Bhosle, J.
    Davidson, M.
    Minchom, A.
    Yousaf, N.
    O'Brien, M.
    Popat, S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S88 - S89
  • [2] Frequency of Uncommon EGFR Mutations in NSCLC in an Argentinean University Institution
    Gabay, Carolina
    Krasnapolski, Martin
    Nazareth Rusjan, Maria
    Gimenez, Liliana
    Rojas Bilbao, Erica
    Thompson, Luis
    Castro, Monica
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S492 - S492
  • [3] EGFR Uncommon Mutations Frequency in a 1,688 NSCLC Patients Database in Brazil
    Ferreira, C.
    Zalis, M.
    Montenegro, G.
    Custodio, M.
    Zukin, M.
    Castro, G., Jr.
    Mathias, C.
    Haddad, C.
    De Lima, V.
    Araujo, L.
    Baldotto, C.
    Gelatti, A.
    Bustamante, C.
    Souza, A.
    Reis, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (09) : S157 - S157
  • [4] EGFR mutations in patients with advanced NSCLC
    Fiala, Ondrej
    Pesek, Milos
    Finek, Jindrich
    Bruha, Frantisek
    Bortlicek, Zbynek
    Krejci, Jana
    Benesova, Lucie
    Minarik, Marek
    [J]. LUNG CANCER, 2012, 77 : S30 - S30
  • [5] Rationale and Design of a Phase II Trial of Dacomitinib in Advanced NSCLC Patients with Uncommon EGFR Mutations
    Han, B.
    Zhang, B.
    Shi, C.
    Gao, Z.
    Zhong, H.
    Xiong, L.
    Gu, A.
    Wang, W.
    Chu, T.
    Zhang, W.
    Wang, H.
    Zhang, X.
    Zhong, R.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S613 - S613
  • [6] Clinicopathologic characteristics of NSCLC patients with uncommon EGFR mutations in Korea
    Lee, Yoo Jung
    Yeo, Chang Dong
    Park, Chan Kwon
    Kim, Sung Kyoung
    Kim, Ju Sang
    Kim, Yong Hyun
    Kim, Jin Woo
    Kim, Seung Joon
    Lee, Sang Haak
    Kang, Hye Seon
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [7] Afatinib for the Treatment of NSCLC with Uncommon EGFR Mutations: A Narrative Review
    Jiang, Yingying
    Fang, Xiaoxu
    Xiang, Yan
    Fang, Tingwen
    Liu, Jingwen
    Lu, Kaihua
    [J]. CURRENT ONCOLOGY, 2023, 30 (06) : 5337 - 5349
  • [8] Clinicopathologic characteristics of NSCLC patients with uncommon EGFR mutations in Korea
    Kang, Hye Seon
    Kim, Kyu Yeon
    Lim, Jeong Uk
    Yeo, Chang Dong
    Kim, Ju Sang
    Kim, Seung Joon
    Lee, Sang Haak
    [J]. RESPIROLOGY, 2023, 28 : 100 - 100
  • [9] Investigation of age and smoking in NSCLC patients with uncommon EGFR mutations
    Maezawa, Yosuke
    Taguchi, Manato
    Kawakami, Takeshi
    Inui, Toshihide
    Okauchi, Shinichiro
    Numata, Takeshi
    Shiozawa, Toshihiro
    Miyazaki, Kunihiko
    Nakamura, Ryota
    Iguchi, Kesato
    Endo, Takeo
    Sakamoto, Tohru
    Satoh, Hiroaki
    Hizawa, Nobuyuki
    [J]. TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, 2024, 72 (02): : 107 - 113
  • [10] Safety and Efficacy of Aumolertinib in Patients with advanced NSCLC Harboring Uncommon EGFR Mutations: Cohort 2 Updated
    Fang, W. F.
    Bu, Q.
    Wang, Q. M.
    Zhao, W. H.
    Wang, L. P.
    Dong, X. R.
    Chen, P. F.
    Wen, Z. B.
    Jia, J.
    Jiang, G. M.
    Zhang, L.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S333 - S334
12345